Copyright
©The Author(s) 2023.
World J Clin Cases. Oct 26, 2023; 11(30): 7350-7362
Published online Oct 26, 2023. doi: 10.12998/wjcc.v11.i30.7350
Published online Oct 26, 2023. doi: 10.12998/wjcc.v11.i30.7350
Table 5 Efficacy of different comparisons of drugs for adverse events by ORs and corresponding 95%CI
| Alendronate | 0.18 (0.01, 2.18) | 0.36 (0.02, 5.83) | 0.89 (0.16, 4.76) |
| 5.64 (0.46, 97.29) | Placebo | 2 (0.14, 33.59) | 4.91 (0.78, 49) |
| 2.8 (0.17, 56.64) | 0.5 (0.03, 7.4) | Risedronate | 2.46 (0.27, 30.06) |
| 1.13 (0.21, 6.23) | 0.2 (0.02, 1.28) | 0.41 (0.03, 3.74) | Teriparatide |
- Citation: He XY, Chen HX, Zhao ZR. Efficacy and safety of different anti-osteoporotic drugs for the spinal fusion surgery: A network meta-analysis. World J Clin Cases 2023; 11(30): 7350-7362
- URL: https://www.wjgnet.com/2307-8960/full/v11/i30/7350.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v11.i30.7350